Arthroscopic Treatment for Femoral Acetabular Impingement Syndrome With Gluteus Medius Lesions.

Femoral Acetabular Impingement Clinical Trial

Official title:

Arthroscopic Treatment for Femoral Acetabular Impingement Syndrome With Gluteus Medius Lesions.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04951180
• Other study ID #: M2021221
• Status: Recruiting
• Start date: May 1, 2021
• Est. completion date: December 1, 2021

Study information

• Verified date: June 2021
• Source: Peking University Third Hospital
• Contact: Jian-quan Wang, M.D.
• Phone: +8613801076267
• Email: keny1417[@]vip.sina.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate the prognosis of femoral acetabular impingement syndrome (FAIS) patients with gluteus medius lesions after hip arthroscopy.

Description:

The data of FAIS patients with gluteus medius lesions were retrospectively extracted pre- and postoperatively after hip arthroscopy. The prognosis of the surgery was evaluated through MRI images.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: December 1, 2021
• Est. primary completion date: August 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria

• Diagnosed FAIS

• Ineffective conservative treatment

• Available pre- and postoperative images

Exclusion Criteria

• Revision arthroscopy

• Osteoarthritis

• History of hip joint disease or surgery

• Sacroiliac joint disease

• Loss of follow-up

Related Conditions & MeSH terms

• Femoracetabular Impingement
• Femoral Acetabular Impingement

Intervention

Other:
• Demographic data and MRI images extraction
The data were retrospectively extracted pre- and postoperatively after hip arthroscopy. The prognosis of the surgery was evaluated through MRI images.

Locations

Country	Name	City	State
China	Peking University Third Hospital	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MRI images	Characteristics of postoperative MRI images	at least 1-year after hip arthroscopy